Amy Peterson
2022 - CytomX Therapeutics
In 2022, Amy Peterson earned a total compensation of $1.8M as Former President and Chief Operating Officer at CytomX Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
Option Awards | $489,960 |
---|---|
Salary | $445,752 |
Stock Awards | $165,200 |
Other | $747,123 |
Total | $1,848,035 |
Peterson received $747.1K in other compensation, accounting for 40% of the total pay in 2022.
Peterson also received $490K in option awards, $445.8K in salary and $165.2K in stock awards.
Rankings
In 2022, Amy Peterson's compensation ranked 1,854th out of 5,501 executives tracked by ExecPay. In other words, Peterson earned more than 66.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,854 | 66th |
Manufacturing | 974 | 67th |
Chemicals And Allied Products | 403 | 70th |
Drugs | 368 | 70th |
Pharmaceutical Preparations | 262 | 71st |
Peterson's colleagues
We found four more compensation records of executives who worked with Amy Peterson at CytomX Therapeutics in 2022.
News
CytomX Therapeutics CEO Sean McCarthy's 2022 pay falls 31% to $3M
April 27, 2023
CytomX Therapeutics CEO Sean McCarthy's 2021 pay jumps 52% to $4.3M
April 27, 2022
BeiGene, Ltd. CEO John Oyler's 2019 pay falls 55% to $13M
April 28, 2020
BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
April 29, 2019